Past Events

The 2016 TB Summit: 21st – 23rd June 2016



 This annual three day event will explore new research into TB detection, treatment and vaccination as well as new developments in controlling and preventing Mycobacterium tuberculosis Infection.

With an informal academic atmosphere and international speakers, it is the perfect environment for debate and discussion.

Agend    Abstract book


The Deadline for abstract submissions for oral presentation is 10th March 2016

The early registration deadline is 20th April 2016

The Deadline for abstract submissions for poster presentation is 5th June 2016

Who Should Attend:  This event welcomes those working within tuberculosis research and treatment, drug discovery, global health, physicians and those working on novel technologies related to TB detection and control.



Fighting Back Against Infectious Diseases – 5th – 7th September 2017

The 2016 TB Summit has an open abstract session:  Abstracts can be submitted on any subject related to Mycobacterium Tuberculosis 

Talks Include

Talk TitleSpeakerAffiliationCountry
Communicating risks and benefits of preventive tuberculosis treatment for shared decision makingDr. Claudia DoblerUniversity of New South WalesAustralia
On the identifiability of transmission dynamic models for infectious diseasesDr. Jarno LintusaariAalto UniversityFinland
Integrated interdisciplinary approaches to tackle extensively drug resistance in TBDr Sanjib BhaktaUniversity of London United Kingdom
TB in healthcare workersProfessor Albert NienhausUniversity Medical Center Hamburg-EppendorfGermany
Host defence mechanisms during early stages of tuberculosis in zebrafishProfessor Annemarie H. Meijer Leiden UniversityNetherlands
Intracellular growth of Mycobacterium tuberculosis; linking microbial physiology to drug development.Dr. Yossef Av-GayThe University of British ColumbiaCanada
Understanding and intervening in HIV-tuberculosisDr. Robert J WilkinsonUniversity of Cape TownSouth Africa
Tuberculosis therapeutics that inhibit bacterial sensing and resistance to host immunityDr. Rob AbramovitchMichigan State UniversityUnited States
A vaccine pipeline - phage display for biomarker identification and generation of human antibodies for diagnostics and therapyDr. Michael HustUniversität BraunschweigGermany
TBCDr Amador GoodridgeINDICASAT-AIPPanama
Coughing and the transmission of tuberculosisDr. Richard TurnerHomerton University Hospital NHS Foundation TrustUnited Kingdom
Extensive Drug Resistant Tuberculosis plus Linezolid Resistance:  Linezolid resistance development in Lisbon, PortugalIsabel PortugalUniversity of LisbonPortugal
TB persisters - resistance is futile, time to end them allDr. Yanmin HuSt George's University of LondonUnited Kingdom
Development of Dinitrobenzyl Oxadiazoles and Thiadiazoles as Selective Antitubercular AgentsDr Jaroslav RohCharles University in PragueCzech Republic
Design and synthesis of antitubercular small molecules targeting drug-resistant mycobacteriaDr. Daniele CastagnoloKing's College LondonUnited Kingdom
Development and deployment of new TB drugsDr. Gerry DaviesLiverpool, LiverpoolUnited Kingdom
TBCDr. Frédéric J. VeyrierINRS-Institut Armand-FrappierCanada
Recent Developments in Childhood Tuberculosis

Dr. James A SeddonImperial College LondonUnited Kingdom
Adjunctive immunotherapy of tuberculosis using vitamin D and phenylbutyrate: a randomized double-blind clinical trialDr. Susanna BrighentiKarolinska InstitutetSweden
3 million TB cases missing: can community based services find them?Professor Luis E. CuevasSchool of Tropical MedicineUnited Kingdom
Assessment of terbium (III) as a probe for the detection of tuberculosis biomarkersDr. Thu-Hoa Tran-ThiCentre national de la recherche scientifiqueFrance
Capturing Geographic Complexity in a Homeless “Neighborhood”: spatial video geonarratives (SVG) in Skid Row, Los AngelesProfessor Andrew CurtisKent State UniversityUnited States
Understanding TB transmission with whole-genome sequencing and modellingDr. Caroline ColijnImperial College LondonUnited Kingdom
Improvements in Energetics-Based Methods for Target Identification in TB Drug DiscoveryDr. Cristiano V. BizarroPontifícia Universidade Católica do Rio Grande do Sul - PUCRSBrazil
The Mtb Divisome: Initial Structural Efforts on Drug TargetsDr. Timothy A. CrossFlorida State UniversityUnited States
TBCProfessor Onn Min KonImperial College Healthcare NHS TrustUnited Kingdom
Plant natural products for TB treatment and prophylaxisDr. R. S. SanthoshSASTRA University India
Rapid differentiation of MycobacteriaDr Linda StewartQueen's UniversityUnited Kingdom
TBCProfessor Dirk SchnappingerWeill Cornell Medical CollegeUnited States
TB or not TB? - Metabolomics may hold the answerProfessor Du Toit LootsNorth-West UniversitySouth Africa
TaqMan Array Card for genotypic drug resistance testingProfessor Eric R. HouptUniversity of VirginiaUnited States
TBCDr Dimitrios EvangelopoulosUniversity College LondonUnited Kingdom
The role of human gamma/delta T cells in the immunity against the infection of Mycobacterium tuberculosis.Dr. Baiqing LiBengbu Medical CollegeChina
PURE-TB-LAMP: Simple & Rapid screenging test for TBDr Yasuyoshi Mori, EikeChemical Co.,LtdJapan
Genomes, structural biology and drug discovery: Understanding antimicrobial resistance in tuberculosisProfessor Tom Blundell University of CambridgeUnited Kingdom
TBCDr. Ill Young LeeKorea Research Institute of Chemical TechnologySouth Korea
Plants a source of antitubercular agentsDr. Maria del Rayo Camacho-CoronaUniversidad Autónoma de Nuevo LeónMexico
Transcriptional Regulation in MycobacteriaDr. Eric Galburt, WashingtonUniversity School of MedicineUnited States
Innate immune recognition of pathogenic mycobacteriaDr. Antje BlumenthalThe University of Queensland Diamantina InstituteAustralia
Toxin:antitoxin modules as regulators of TB growth and persistenceAssociate Professor Shaleen KorchMidwestern UniversityUnited States
"Bring me back to life" - resuscitation of dormant mycobacteria.Dr. Galina Mukamolovaniversity of LeicesterUnited Kingdom
Purinergic signaling in the immune response to severe tuberculosisProfessor Maria Regina D'Imperio LimaUniversidade de São PauloBrazil
IFITM family members restrict Mycobacterium tuberculosis infectionDr Shahin RanjbarHarvard Medical SchoolUnited States
TBCDr Prakash Udhawdas Tahiliani Prime Ever Ayurvedic Research LaboratoriesIndia
Multiple Biomarkers for Reliable Identification of Mycobacterium Tuberculosis Complex in Broth Culture Media with NanodiamondProfessor Peng Wen-PingNational Dong Hwa UniversityTaiwan
De novo design of short synthetic membrane-targeting anti-mycobacterial peptides.Jasmeet Singh KharaImperial College LondonUnited Kingdom
Next Generation Tuberculosis Diagnostics: Test and TreatDr. Elisa TaglianiEmerging Bacterial Pathogens UnitItaly
A vaccine pipeline: phage display for identification of vaccine candidates, and generation of human antibodies for diagnostics and therapyDr. Gustavo MoreiraTechnische Universität Braunschweig

Advisory Board Members

Dr Tomoshige Matsumoto Osaka Anti-Tuberculosis Association Japan
Professor Edith Sim University of Oxford United Kingdom
Mr Michel Baltas CNRSFrance
Dr Sandrine Lesellier Animal and Plant Health Agency (APHA) United Kingdom
Professor P K Das University of AmsterdamThe Netherlands

CPD Credits

Related Past Agendas


Mycobacterium Tuberculosis Infection Treatment – 26th March 2014

Mycobacterium Tuberculosis Infection Detection – 25th March 2014

Mycobacterium Tuberculosis Infection Prevention – 24th March 2014 Forensic Investigations to locate and identify the missing – 5th March 2014

Mycobacterium tuberculosis……can we beat it  – 21 March 2013


Email:? enquiries [@]

Phone:?(+44) 020 3807 3712

Abstract and Poster Presentations

All abstracts accepted for oral presentation are also automatically accepted for poster presentation


Cancellation Policy

Join the conversation

Related past events




This is a closed event

Only participants who have registered are licensed to attend this event. This is for the protection and peace of mind of our speakers who are presenting unpublished work. We ask our participants not to share their screen with people who are not registered for the event and will fine those who do.

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: